Clinical Trial Update: A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the pharmacokinetics, pharmacodynamics, and safety of bimekizumab in adults with plaque psoriasis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Chronic Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2021-01-06